These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37333968)

  • 1. The impact of pharmacy benefit managers on community pharmacy: A scoping review.
    Rosenthal M; Miller L; Bateman M; Smith M; Nueva K; Ballou JM
    Explor Res Clin Soc Pharm; 2023 Jun; 10():100283. PubMed ID: 37333968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy.
    Mattingly TJ; Hyman DA; Bai G
    JAMA Health Forum; 2023 Nov; 4(11):e233804. PubMed ID: 37921745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-level policy efforts to regulate pharmacy benefit managers (PBMs).
    Mattingly TJ; Lewis M; Socal MP; Bai G
    Res Social Adm Pharm; 2022 Nov; 18(11):3995-4002. PubMed ID: 35934666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.
    Royce TJ; Schenkel C; Kirkwood K; Levit L; Levit K; Kircher S
    JCO Oncol Pract; 2020 May; 16(5):276-284. PubMed ID: 32310720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication review service implementation in community pharmacy settings: Scoping review with focus on implementation studies.
    Brandt J; Lê ML; Jantscher S; Bricelj A; Louizos C; Ng S; Sibley K
    Res Social Adm Pharm; 2020 Jul; 16(7):875-885. PubMed ID: 31606298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.
    Greenapple R
    Am Health Drug Benefits; 2012 Jul; 5(4):242-53. PubMed ID: 24991323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing Evolution over Extinction: Integrating Direct Patient Care Services and Value-Based Payment Models into the Community-Based Pharmacy Setting.
    Mercadante AR; Yokota M; Hwang A; Hata M; Law AV
    Pharmacy (Basel); 2020 Jul; 8(3):. PubMed ID: 32722217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes, costs and stakeholders' perspectives associated with the incorporation of community pharmacy services into the National Health Insurance System in Thailand: a systematic review.
    Asayut N; Sookaneknun P; Chaiyasong S; Saramunee K
    Int J Pharm Pract; 2018 Feb; 26(1):16-27. PubMed ID: 28795519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for measuring prescription medication switching with pharmacy claims data: a scoping review protocol.
    Harris DA; Bouck Z; Tricco AC; Cadarette SM; Iaboni A; Bronskill SE
    JBI Evid Synth; 2021 Sep; 19(9):2441-2456. PubMed ID: 33720110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy interventions on COVID-19 in Europe: Mapping current practices and a scoping review.
    Costa S; Romão M; Mendes M; Horta MR; Rodrigues AT; Carneiro AV; Martins AP; Mallarini E; Naci H; Babar ZU
    Res Social Adm Pharm; 2022 Aug; 18(8):3338-3349. PubMed ID: 34924315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educational needs of community pharmacy staff in minor ailment service delivery: A systematic scoping review.
    Aly M; Schneider CR; Sukkar MB; Lucas C
    Curr Pharm Teach Learn; 2020 Oct; 12(10):1269-1287. PubMed ID: 32739065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies.
    MacKeigan LD; Ijaz N; Bojarski EA; Dolovich L
    Res Social Adm Pharm; 2017; 13(5):947-958. PubMed ID: 28462792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blueprint for pharmacy benefit managers to increase value.
    Shrank WH; Porter ME; Jain SH; Choudhry NK
    Am J Manag Care; 2009 Feb; 15(2):87-93. PubMed ID: 19284805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role and impact of pharmacists in Spain: a scoping review.
    Saavedra-Mitjans M; Ferrand É; Garin N; Bussières JF
    Int J Clin Pharm; 2018 Dec; 40(6):1430-1442. PubMed ID: 30367376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application and utility of geographic information systems in pharmacy specific health research: A scoping review.
    Fernandes BD; Foppa AA; Almeida PHRF; Lakhani A; Lima TM
    Res Social Adm Pharm; 2022 Aug; 18(8):3263-3271. PubMed ID: 34836813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand.
    Hansen RA; Roth MT; Brouwer ES; Herndon S; Christensen DB
    J Am Pharm Assoc (2003); 2006; 46(6):700-6. PubMed ID: 17176685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.